| Entry |
|
|---|
| Name |
Dasiglucagon (USAN) |
|---|
| Formula |
C152H222N38O50
|
|---|
| Exact mass |
3379.5997
|
|---|
| Mol weight |
3381.61
|
|---|
| Sequence |
HSQGTFTSDY SKYLDXARAE EFVKWLEST |
|---|
| Type |
Peptide |
|---|
| Remark |
| Product (DG03173): | D12314<US> |
|
|---|
| Efficacy |
Antidiabetic, Antihypoglycemia, Glucagon receptor agonist |
|---|
| Disease |
|
|---|
| Comment |
Glucagon analogue
Treatment of hypoglycemia in type 1 and type 2 diabetes patients
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H04 PANCREATIC HORMONES
H04A GLYCOGENOLYTIC HORMONES
H04AA Glycogenolytic hormones
H04AA02 Dasiglucagon
D11359 Dasiglucagon (USAN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Secretin receptor family
Glucagon
GCGR
D11359 Dasiglucagon (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
